Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06802874

Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to assess in terms of frequency the adverse outcomes (premature birth, maternal-fetal haemorrhage, maternal fetal-neonatal death) of pregnancies of women attending the obstetric-gynaecological emergency department for genital bleeding beyond the 18th week of pregnancy.

Detailed description

The investigators decided to conduct this study because it is important on the one hand to carefully evaluate maternal-fetal outcomes in pregnancies characterised by genital bleeding in the second and third trimesters and on the other hand to evaluate the sonographic diagnostic capacity for identifying the aetiology of these genital bleedings, in order to understand whether the possibility of identifying a specific cause of the bleeding has also improved over time as sonographic techniques have improved. This could then allow management and subsequent obstetrical controls to be adapted in a more accurate and indivudualised manner. For the purpose of this study, no study-specific visits are planned. Data collected during pregnancy and delivery data for patients who gave birth at our centre will be analysed.

Conditions

Timeline

Start date
2023-11-15
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-01-31
Last updated
2025-01-31

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06802874. Inclusion in this directory is not an endorsement.

Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy (NCT06802874) · Clinical Trials Directory